# Cadrenal Therapeutics, Inc.: Form DEF 14A, filed Aug 3, 2026

- Company: [Cadrenal Therapeutics, Inc.](/companies/cvkd.md) (CIK 1937993)
- Form: DEF 14A
- Filed: 2026-08-03
- Accepted by EDGAR: Aug 3, 2026, 21:09 ET
- Period: 2026-09-24
- Accession: 0001213900-26-084710
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1937993/000121390026084710/ea0298910-02.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1937993/000121390026084710/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1937993/000121390026084710/ea0298910-02.htm

Filed Aug 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-084710. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.